EUVIMEDEUVIMED entdecken
Crossref

Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics

Nishant Kumar Jain iD, Shubham Pallod, Berney Peng, Rohini Kumari, Deepak Singh Chauhan, Mukesh Dhanka, Eaint Honey Aung Win, Michael A Teitell iD, Pranjal Chandra iD, Rohit Srivastava iD, Rajendra Prasad iD

ACS Applied Bio Materials · 2024

DOI: 10.1021/acsabm.4c00409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Nishant Kumar Jain und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India. Hauptthemen laut MEDLINE: Gold, Doxorubicin, Drug Screening Assays, Antitumor, Metal Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surface-engineered gold nanoparticles have been considered as versatile systems for theranostics applications. Moreover, surface covering or stabilizing agents on gold nanoparticles especially gold nanobipyramids (AuNBPs) provides an extra space for cargo molecules entrapment. However, it is not well studied yet and also the preparation of AuNBPs still remains dependent largely on cetyltrimethylammonium bromide (CTAB), a cytotoxic surfactant. Therefore, the direct use of CTAB stabilized nanoparticles is not recommended for cancer theranostics applications. Herein, we address an approach of dodecyl ethyl dimethylammonium bromide (DMAB) as biocompatible structure directing agent for AuNBPs, which also accommodate anticancer drug doxorubicin (45%), an additional chemotherapeutics agent. Upon near-infrared light (NIR, 808 nm) exposure, engineered AuNBPs exhibit (i) better phototransduction (51 °C) due to NIR absorption ability (650-900 nm), (ii) photo triggered drug release (more than 80%), and (iii) synergistic chemophototherapy for breast cancer cells. Drug release response has been evaluated in tumor microenvironment conditions (84% in acidic pH and 80% at high GSH) due to protonation and high affinity of thiol binding with AuNBPs followed by DMAB replacement. Intracellular glutathione (GSH, 5-7.5 mM) replaces DMAB from AuNBPs, which cause easy aggregation of nanoparticles as corroborated by colorimetric shifts, suggesting their utilization as a molecular sensing probe of early stage cancer biomarkers. Our optimized recipe yield is monodisperse DMAB-AuNBPs with ∼90% purity even at large scales (500 mL volume per batch). DMAB-AuNBPs show better cell viability (more than 90%) across all concentrations (5-500 ug/mL) when directly compared to CTAB-AuNBPs (less than 10%). Our findings show the potential of DMAB-AuNBPs for early stage cancer detection and theranostics applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldDoxorubicinDrug Screening Assays, AntitumorMetal NanoparticlesParticle SizeHumansBiocompatible MaterialsAntineoplastic AgentsMaterials TestingCell SurvivalCell ProliferationCell Line, TumorDrug LiberationMolecular Structure

Stichwörter der Autor:innen

bioimagingcancer cell detectiondrug deliverynanobipyramidsplasmonic nanoparticlessynergistic therapeutics

Substanzen

GoldDoxorubicinBiocompatible MaterialsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India.
  • Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California 90095, United States.
  • School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh 221005, India.
  • Department of Microbiology and Immunology, Dalhousie University, Halifax, NS 6299, Canada.
  • Department of Pediatrics, IWK Research Center, Halifax, Nova Scotia 6299, Canada.
  • Department of Biological Sciences and Engineering, Indian Institute of Technology Gandhinagar 382055, Gujarat India.

ORCID-Profile: Nishant Kumar Jain, Michael A Teitell, Pranjal Chandra, Rohit Srivastava, Rajendra Prasad

Förderung

  • Indian Council of Medical Research
  • Department of Biotechnology, Ministry of Science and Technology, India
  • School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi

Zitieren

APA

Jain, N. K., Pallod, S., Peng, B., Kumari, R., Chauhan, D. S., Dhanka, M., Aung Win, E. H., Teitell, M. A., Chandra, P., Srivastava, R., & Prasad, R. (2024). Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00409

Vancouver

Jain NK, Pallod S, Peng B, Kumari R, Chauhan DS, Dhanka M, et al. Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00409

BibTeX
@article{Jain2024,
  author = {Jain, Nishant Kumar and Pallod, Shubham and Peng, Berney and Kumari, Rohini and Chauhan, Deepak Singh and Dhanka, Mukesh and Aung Win, Eaint Honey and Teitell, Michael A and Chandra, Pranjal and Srivastava, Rohit and Prasad, Rajendra},
  title = {Stimuli Responsive Molecular Exchange of Structure Directing Agents on Gold Nanobipyramids: Cancer Cell Detection and Synergistic Therapeutics},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  doi = {10.1021/acsabm.4c00409}
}
Kostenlos starten →